Actionability and scope should determine the extent of counselling for presymptomatic genetic testing | Zendy

Bettina Zimmermann | Zendy; Georg Starke | Zendy; David Shaw | Zendy; Bernice S. Elger | Zendy; Insa Koné | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Actionability and scope should determine the extent of counselling for presymptomatic genetic testing

Author(s) -

Bettina Zimmermann,

Georg Starke,

David Shaw,

Bernice S. Elger,

Insa Koné

Publication year - 2020

Publication title -

schweizerische medizinische wochenschrift

Language(s) - English

Resource type - Journals

ISSN - 0036-7672

DOI - 10.4414/smw.2020.20274

Subject(s) - medicine , scope (computer science) , genetic testing , genetic counseling , family medicine , medical physics , genetics , biology , computer science , programming language

Patients considering undergoing presymptomatic genetic and genomic testing commonly receive prior genetic counselling. However, there is a need to discuss further why genetic counselling has such unique and high importance in many countries worldwide. This discussion will help to rationalise resource allocations within healthcare systems and improve patient communication in genetics and other fields.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research